1.罗新锦，孙寒松.心室辅助装置.胡盛寿.阜外心血管外科手册.北京：人民卫生出版社，2006：267-272.

2.孙寒松，罗新锦.心脏辅助装置.华伟，张澍.充血性心力衰竭的非药物治疗.北京：人民卫生出版社，2008：227-245.

3.Rouleau JL，Bonow RO.An approach to the rational use of revascularization in heart failure patients.Can J Cardiol，2014，30（3）：281-287.

4.Atluri P，Acker MA.Mitral valve surgery for dilated cardiomyopathy：current status and future Roles.Semin Thorac Cardiovasc Surg，2012，24（1）：51-58.

5.Daggubati R，Arumugham P，Ferguson TB Jr.The world post STICH：is this a“Game Changer？”A surgeon’s perspective—revascularization is still the treatment of choice.Prog Cardiovasc Dis，2013，55（5）：470-475.

6.Balsam LB，Grossi EA.Surgical ventricular reconstruction has a role in surgical remodeling in patients with LV systolic dysfunction even post-STICH.Prog Cardiovasc Dis，2013，55（5）：481-486.

7.Massad MG，Prasad SM，Chedrawy EG，et al.A perspective on the surgical mangment of congestive heart failure.World J Surg，2008，32（3）：375-380.

8.Allen LA，Felker GM.Advances in the surgical treatment of heart failure.Curr Opin Cardiol，2008，23（3）：249-253.

9.Blom AS，Acker MA.The surgical treatment of end-stage heart failure.Curr Probl Cardiol，2007，32（10）：553-599.

10.Buckberg GD，Athanasuleas CL.The STICH trial：misguided conclusions.J Thorac Cardiovasc Surg，2009，138（5）：1060-1064.

11.Sanganalmath SK，Bolli R.Cell therapy for heart failure：A comprehensive overview of experiment and clinical studies，current challenges，and future directions.Circ Res，2013，113（6）：810-834.

12.Law P.First human heart myoblast allograft.J Am Coll Cardiol，2004，43：39.

13.Meanaché P.Cellular transplantation：hurdles remaining before widespread clinical use.Curr Opin Cardiol，2004，19（2）：154-161.

14.Dor V，Civaia F，Alexandrescu C，et al.Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure（STICH）trial.J Thorac Cardiovasc Surg，2011，141（4）：905-916.

15.Isomura T，Hoshino J，Fukada Y，et al.Volume reduction rate by surgical ventricular restoration determines late outcome in ischaemic cardiomyopathy.Eur J Heart Fail，2011，13（4）：423-431.

16.Di Donato M，Castelvecchio S，Menicanti L.End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy.Eur J Heart Fai，2010，12（4）：375-381.

17.Mann DL，Kubo SH，Sabbah HN，et al.Beneficial effects of the CorCap cardiac support device：five-year results from the Acorn Trial.J Thorac Cardiovasc Surg，2012，143（5）：1036-1042.

18.Acker MA，Bolling S，Shemin R，et al.Mitrial valve surgery in heart failure：insights from Acorn Clinical Trial.J Thorac Cardiovasc Surg，2006，132（3）：568-577.

19.Fukamachi K，McCarthy PM.Initial safety and feasibility clinical trial of the Myosplint Device.J Card Surg，2005，20（6）：43-47.

20.Grossi EA，Saunders PC，Woo YJ，et al.Intraoperative effects of Coapsys annuloplasty system in randomized evaluation（RESTOR-MV）of functional ischemic mitral regurgitation.Ann Thorac Surg，2005，80（5）：1706-1711.

21.Mishra YK，Mittal S，Jaguri P，et al.Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation：1-year results.Ann Thorac Surg，2006，81（1）：42-46.

22.Mittal S，Mishra Y，Trehan N.Coapsys ^® leads to global reversal of left ventricular remodeling：expanded TRACE study analysis.Circulation，2007，116：11-373.

23.Carrick R，Ge L，Lee LC，et al.Patient-specific finite element-based analysis of ventricular myofiber stress after Coapsys：importance of residual stress.Ann Thorac Surg，2012，93（6）：1964-1971.

24.Rigatelli G，Santini F，Faggian G.Past and present of cardiocirculatory assist devices：a comprehensive critical review.J Geriatr Cardiol，2012，9（4）：389-400.

25.Kasirajan V，Tang DG，Katlaps GJ，et al.The total artificial heart for biventricular heart failure and beyond.Curr Opin Cardiol，2012，27（3）：301-307.Lee S，Fukamachi K，Golding L，et al.Left ventricular assist devices：from the bench to the clinic.Cardiology，2013，125（1）：1-12.

26.Kirklin JK，Naftel DC，Kormos RL，et al.The fourth INTERMACS annual report：4000 implants and counting.J Heart Lung Transplant，2012，31（2）：117-126.

27.Miller LW，Pagani FD，Russell SD，et al.Use of a continuousflow device in patients awaiting heart transplantation.N Engl J Med，2007，357（9）：885-896.

28.Slaughter MS，Rogers JG，Milano CA，et al.Advanced heart failure treated with continuous-flow left ventricular assist device.N Engl J Med，2009，361（23）：2241-2251.

29.Park SJ，Milano CA，Tatooles AJ，et al.Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.Circ Heart Fail，2012，5（2）：241-248.

30.Rogers JG，Aaronson KD，Boyle AJ，et al.Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.J Am Coll Cardiol，2010.55（17）：1826-1834.

31.Pauliks LB，Undar A.New devices for pediatric mechanical circulatory support.Curr Opin Cardiol，2008，23（2）：91-96.